Former executive at Pharmaceutical Product Development Inc (PPD)
- CRO (contract research organisation) market trends and themes
- Competitive landscape across the CRO industry – Iqvia (NYSE: IQV), PPD (NASDAQ: PPD), Covance (NYSE: LH), Charles River Laboratories (NYSE: CRL)
- Contracting models in the CRO industry – product-based services vs outcome-based models
- CRO focus on patient centricity and DCTs (decentralised clinical trials)
- 12-18-month growth outlook for the CRO industry
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.